Controlled Settings for Lung Cancer Screening: Why Do They Matter? Considerations for Referring Clinicians
1
Dalla Lana School of Public Health, University of Toronto, and Canadian Partnership Against Cancer, Toronto, ON, Canada
2
Canadian Partnership Against Cancer, Toronto, ON, Canada
3
Department of Integrative Oncology, BC Cancer Research Centre, Vancouver, BC, Canada
4
Terry Fox Research Institute, Vancouver, BC, Canada
5
Department of Medicine, University of British Columbia, Vancouver, BC, Canada
6
Canadian Partnership Against Cancer, Toronto, ON, Canada
7
Departments of Community Health Sciences and of Oncology, University of Calgary, Calgary, AB, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2016, 23(6), 371-373; https://doi.org/10.3747/co.23.3430
Submission received: 16 September 2016
/
Revised: 11 October 2016
/
Accepted: 17 November 2016
/
Published: 1 December 2016
Excerpt
Note: In lieu of an abstract, this is an excerpt from the first page.
The updated guideline on lung cancer screening released in March 2016 by the Canadian Task Force on Preventive Health Care recommends screening for people at high risk for lung cancer.[...]
Share and Cite
MDPI and ACS Style
Bharmal, A.; Crosskill, A.; Lam, S.; Bryant, H. Controlled Settings for Lung Cancer Screening: Why Do They Matter? Considerations for Referring Clinicians. Curr. Oncol. 2016, 23, 371-373. https://doi.org/10.3747/co.23.3430
AMA Style
Bharmal A, Crosskill A, Lam S, Bryant H. Controlled Settings for Lung Cancer Screening: Why Do They Matter? Considerations for Referring Clinicians. Current Oncology. 2016; 23(6):371-373. https://doi.org/10.3747/co.23.3430
Chicago/Turabian StyleBharmal, A., A. Crosskill, S. Lam, and H. Bryant. 2016. "Controlled Settings for Lung Cancer Screening: Why Do They Matter? Considerations for Referring Clinicians" Current Oncology 23, no. 6: 371-373. https://doi.org/10.3747/co.23.3430
